Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 0 | 0 | 0 | 119,445 | 17,446 |
| Gross Profit | N/A | N/A | 0 | 119,445 | 17,446 |
| Operating Expenses | 28,249 | 27,185 | 23,532 | 21,598 | 25,453 |
| Operating Income | -28,249 | -27,185 | -23,532 | 97,847 | -8,007 |
| Other Income | 285 | 750 | 875 | 1,025 | 1,026 |
| Pre-tax Income | -27,964 | -26,435 | -22,657 | 98,872 | -6,981 |
| Income Tax | 4 | 8 | 10 | 12 | 12 |
| Net Income Continuous | -27,968 | -26,443 | -22,667 | 98,860 | -6,993 |
| Net Income | $-27,968 | $-26,443 | $-22,667 | $98,860 | $-6,993 |
| EPS Basic Total Ops | -0.82 | -0.78 | -0.68 | 2.99 | -0.21 |
| EPS Basic Continuous Ops | -0.82 | -0.78 | -0.68 | 2.99 | -0.21 |
| EPS Diluted Total Ops | -0.82 | -0.78 | -0.65 | 2.90 | -0.21 |
| EPS Diluted Continuous Ops | -0.82 | -0.78 | -0.65 | 2.90 | -0.21 |
| EBITDA(a) | $-27,403 | $-26,331 | $-22,820 | $98,466 | $-7,453 |